(Q30311882)

16 June 2017

title

Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils (English)

1 reference

16 June 2017

Gail W Sullivan

1

1 reference

16 June 2017

David D Lee

2

1 reference

16 June 2017

William G Ross

3

1 reference

16 June 2017

Jeffrey A DiVietro

4

1 reference

16 June 2017

Courtney M Lappas

5

1 reference

16 June 2017

Michael B Lawrence

6

1 reference

16 June 2017

Joel Linden

7

1 reference

16 June 2017

publication date

2 October 2003

1 reference

Journal of Leukocyte Biology

16 June 2017

published in

1 reference

16 June 2017

volume

75

1 reference

16 June 2017

issue

1

1 reference

16 June 2017

page(s)

127-134

1 reference

alpha(4)-integrin mediates neutrophil-induced free radical injury to cardiac myocytes

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Functional alpha4-integrin: a newly identified pathway of neutrophil recruitment in critically ill septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Adenosine modulation of tumor necrosis factor-alpha-induced neutrophil activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

KF24345, an adenosine uptake inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production and leukopenia via endogenous adenosine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Adenosine deaminase inhibition attenuates microvascular dysfunction and improves survival in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Human A(2A) adenosine receptors: high-affinity agonist binding to receptor-G protein complexes containing Gbeta(4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Resting murine neutrophils express functional alpha 4 integrins that signal through Src family kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Adenosine, an endogenous anti-inflammatory agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Engagement of adenosine receptors inhibits hydrogen peroxide (H2O2-) release by activated human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Natalizumab for active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

A controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Tumor necrosis factor and CD11/CD18 (beta 2) integrins act synergistically to lower cAMP in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

α4Integrins as Therapeutic Targets in Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0603300

21 January 2018

Identifiers

DOI

10.1189/JLB.0603300

1 reference

16 June 2017

1 reference